Summary of project PR000729

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR000729. The data can be accessed directly via it's Project DOI: 10.21228/M8FM38 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

Project ID: PR000729
Project DOI:doi: 10.21228/M8FM38
Project Title:NMR metabolomics study of Gemcitabine resistant cancer cells
Project Type:NMR metabolomics
Project Summary:1D 1H NMR based differential metabolomics study of T3M4 cells, which are gemcitabine sensitive, and gemcitabine resistant T3M4 cells (GemR) were cultured with or without gemcitabine treatment. 1D 1H NMR spectra were collected from the samples and analyzed using MVAPACK software (http://bionmr.unl.edu/mvapack.php). Using multivariate analysis, unique responses to gemcitabine treatment were revealed, which may be useful in the clinical setting for monitoring a patient’s therapeutic response.
Institute:University of Nebraska-Lincoln
Department:Chemistry
Laboratory:Robert Powers and Pankaj Singh labs
Last Name:Gebregiworgis
First Name:Teklab
Address:552 Hamilton Hall, 639 N. 12th Street, Lincoln, NE, 68588, USA
Email:teklab@huskers.unl.edu
Phone:(402) 472-3039
Funding Source:NCI, NIGMS, AACR
Contributors:Teklab Gebregiworgis, Fatema Bhinderwala, Vinee Purohit, Nina V. Chaika, Pankaj K. Singh, and Robert Powers

Summary of all studies in project PR000729

Study IDStudy TitleSpeciesInstituteAnalysis
(* : Contains Untargted data)
Release
Date
VersionSamplesDownload
(* : Contains raw data)
ST001090 NMR metabolomics study of Gemcitabine resistant cancer cells Homo sapiens University of Nebraska-Lincoln NMR* 2019-10-11 1 40 Uploaded data (4.1M)
  logo